359 related articles for article (PubMed ID: 20197557)
21. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
Mahesh R; Perumal RV; Pandi PV
Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895
[TBL] [Abstract][Full Text] [Related]
22. Granisetron: an update on its clinical use in the management of nausea and vomiting.
Aapro M
Oncologist; 2004; 9(6):673-86. PubMed ID: 15561811
[TBL] [Abstract][Full Text] [Related]
23. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
Aksoylar S; Akman SA; Ozgenç F; Kansoy S
Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
[TBL] [Abstract][Full Text] [Related]
24. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
Cunningham RS
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):33-40. PubMed ID: 9282379
[TBL] [Abstract][Full Text] [Related]
25. Management of chemotherapy-induced nausea and vomiting.
Tortorice PV; O'Connell MB
Pharmacotherapy; 1990; 10(2):129-45. PubMed ID: 2190193
[TBL] [Abstract][Full Text] [Related]
26. Clinical practice guidelines on antiemetics in oncology.
Aranda Aguilar E; Constenla Figueiras M; Cortes-Funes H; Diaz-Rubio García E; Gascon Vilaplana P; Guillém V; Martin-Algarra S
Expert Rev Anticancer Ther; 2005 Dec; 5(6):963-72. PubMed ID: 16336087
[TBL] [Abstract][Full Text] [Related]
27. Nausea and vomiting in advanced cancer.
Harris DG
Br Med Bull; 2010; 96():175-85. PubMed ID: 20884654
[TBL] [Abstract][Full Text] [Related]
28. [The use of navoban in the therapy of oncology patients with highly emetic treatments].
Russel AJ
Vopr Onkol; 1995; 41(1):87-90. PubMed ID: 7667952
[No Abstract] [Full Text] [Related]
29. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction.
Hisanaga T; Shinjo T; Morita T; Nakajima N; Ikenaga M; Tanimizu M; Kizawa Y; Maeno T; Shima Y; Hyodo I
Jpn J Clin Oncol; 2010 Aug; 40(8):739-45. PubMed ID: 20410056
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients.
Aass N; Håtun DE; Thoresen M; Fosså SD
Radiother Oncol; 1997 Nov; 45(2):125-8. PubMed ID: 9424001
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of prophylactic antiemetic treatment in cancer patients receiving radiotherapy.
Mystakidou K; Kouloulias V; Nikolaou V; Tsilika E; Lymperopoulou G; Balafouta M; Kouvaris I; Kelekis A; Gouliamos A
J BUON; 2010; 15(1):29-35. PubMed ID: 20414924
[TBL] [Abstract][Full Text] [Related]
32. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
Goldsmith B
Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
[No Abstract] [Full Text] [Related]
33. Tropisetron (ICS 205-930) in pediatric oncology: first results in patients refractory to antiemetic metoclopramide-based treatments.
Cefalo G; Rottoli L; Armiraglio A; Pagan MG
Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):242-5. PubMed ID: 8037343
[TBL] [Abstract][Full Text] [Related]
34. Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update.
Davis M; Hui D; Davies A; Ripamonti C; Capela A; DeFeo G; Del Fabbro E; Bruera E
Support Care Cancer; 2021 Dec; 29(12):8089-8096. PubMed ID: 34390398
[TBL] [Abstract][Full Text] [Related]
35. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial.
Mystakidou K; Tsilika E; Kalaidopoulou O; Chondros K; Georgaki S; Papadimitriou L
Anticancer Res; 2002; 22(2B):1187-92. PubMed ID: 12168923
[TBL] [Abstract][Full Text] [Related]
36. Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction.
Kaneishi K; Kawabata M; Morita T
J Pain Symptom Manage; 2012 Oct; 44(4):604-7. PubMed ID: 22771132
[TBL] [Abstract][Full Text] [Related]
37. Abdominal cancer, nausea, and vomiting.
Muir JC; von Gunten CF
J Palliat Med; 2001; 4(3):391-4. PubMed ID: 11596551
[TBL] [Abstract][Full Text] [Related]
38. Treatment of nausea and vomiting in advanced cancer.
Davis MP; Walsh D
Support Care Cancer; 2000 Nov; 8(6):444-52. PubMed ID: 11094988
[TBL] [Abstract][Full Text] [Related]
39. [Appetite loss, nausea, vomiting].
Sakamaki S
Nihon Rinsho; 2007 Jan; 65(1):69-75. PubMed ID: 17233418
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : a systematic review].
Benze G; Geyer A; Alt-Epping B; Nauck F
Schmerz; 2012 Sep; 26(5):481-99. PubMed ID: 22983450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
